Nuvalent, Inc.
NUVL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $218 | $113 | $64 | $36 |
| G&A Expenses | $63 | $36 | $22 | $10 |
| SG&A Expenses | $63 | $36 | $22 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $280 | $149 | $86 | $46 |
| Operating Income | -$280 | -$149 | -$86 | -$46 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $20 | $23 | $4 | -$1 |
| Pre-Tax Income | -$260 | -$126 | -$82 | -$46 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | -$261 | -$126 | -$82 | -$46 |
| % Margin | – | – | – | – |
| EPS | -3.93 | -2.17 | -1.65 | -2.13 |
| % Growth | -81.1% | -31.5% | 22.5% | – |
| EPS Diluted | -3.93 | -2.17 | -1.65 | -2.13 |
| Weighted Avg Shares Out | 66 | 58 | 50 | 22 |
| Weighted Avg Shares Out Dil | 66 | 58 | 50 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $38 | $23 | $0 | $0 |
| Interest Expense | $0 | $23 | $0 | $0 |
| Depreciation & Amortization | $280 | $0 | $0 | $0 |
| EBITDA | $0 | -$126 | -$86 | -$46 |
| % Margin | – | – | – | – |